Cases 61 - 70 of 623
MURPHY v. JANSSEN PHARMACEUTICALS, INC. et al
as 2:2022cv02934
Plaintiff:
LINDA MURPHY
Defendant:
JANSSEN PHARMACEUTICALS, INC., f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. f/k/a JANSSEN PHARMACEUTICA INC., ORTHO-MCNEIL JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC and others
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HOLMSTROM v. ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD. et al
as 1:2022cv02882
Plaintiff:
JAMIE HOLMSTROM and THE ESTATE OF ANNETTE GOEBEL
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL, CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MOORE v. JOHNSON & JOHNSON et al
as 2:2022cv02853
Plaintiff:
Lorie A Moore
Defendant:
JOHNSON & JOHNSON, ETHICON US LLC., JANSSEN ORTHO LLC and others
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal- Product Liability
RUPP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02780
Plaintiff:
BERNARD RUPP
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MURPHREE v. JANSSEN PHARMACEUTICALS, INC. et al
as 2:2022cv02795
Plaintiff:
PATRICIA MURPHREE
Defendant:
JANSSEN PHARMACEUTICALS, INC., f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. f/k/a JANSSEN PHARMACEUTICA INC., ORTHO-MCNEIL PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT, LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC and others
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CARRASQUILLO v. JANSSEN PHARMACEUTICALS, INC. et al
as 2:2022cv02790
Plaintiff:
STACEY CARRASQUILLO
Defendant:
JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC, JOHNSON & JOHNSON; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., TEVA PHARMACEUTICALS USA, INC.; and others
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
JACKSON v. JANSSEN PHARMACEUTICALS, INC. et al
as 2:2022cv02791
Defendant:
JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH & DEVELOPMENT LLC, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. and others
Plaintiff:
JANECE JACKSON
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GRAHAM et al v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv02598
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
VANESSA GRAHAM and ANTHONY GRAHAM
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., JOHN DOE, TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THE ESTATE OF CONNIE KEEP v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv02461
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:
AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THE ESTATE OF ROBERT COOPER v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv01635
Plaintiff:
KIM COOPER and THE ESTATE OF ROBERT COOPER
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
